104 related articles for article (PubMed ID: 26844659)
1. Reverse kinetics of angiopoietin-2 and endotoxins in acute pyelonephritis: Implications for anti-inflammatory treatment?
Safioleas K; Giamarellos-Bourboulis EJ; Carrer DP; Pistiki A; Sabracos L; Deliveliotis C; Chrisofos M
Cytokine; 2016 May; 81():28-34. PubMed ID: 26844659
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-2 enhances survival in experimental sepsis induced by multidrug-resistant Pseudomonas aeruginosa.
Tzepi IM; Giamarellos-Bourboulis EJ; Carrer DP; Tsaganos T; Claus RA; Vaki I; Pelekanou A; Kotsaki A; Tziortzioti V; Topouzis S; Bauer M; Papapetropoulos A
J Pharmacol Exp Ther; 2012 Nov; 343(2):278-87. PubMed ID: 22859861
[TBL] [Abstract][Full Text] [Related]
3. Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli.
Giamarellos-Bourboulis EJ; Baziaka F; Antonopoulou A; Koutoukas P; Kousoulas V; Sabracos L; Panagou C; Perrea D; Giamarellou H
Int J Antimicrob Agents; 2005 Feb; 25(2):168-72. PubMed ID: 15664488
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Adamis T; Laoutaris G; Sabracos L; Koussoulas V; Mouktaroudi M; Perrea D; Karayannacos PE; Giamarellou H
Antimicrob Agents Chemother; 2004 Jan; 48(1):93-9. PubMed ID: 14693524
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.
Orfanos SE; Kotanidou A; Glynos C; Athanasiou C; Tsigkos S; Dimopoulou I; Sotiropoulou C; Zakynthinos S; Armaganidis A; Papapetropoulos A; Roussos C
Crit Care Med; 2007 Jan; 35(1):199-206. PubMed ID: 17110873
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-2 is increased in septic shock: evidence for the existence of a circulating factor stimulating its release from human monocytes.
Kranidioti H; Orfanos SE; Vaki I; Kotanidou A; Raftogiannis M; Dimopoulou I; Kotsaki A; Savva A; Papapetropoulos A; Armaganidis A; Giamarellos-Bourboulis EJ
Immunol Lett; 2009 Jun; 125(1):65-71. PubMed ID: 19539650
[TBL] [Abstract][Full Text] [Related]
7. Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Antonopoulou A; Raftogiannis M; Koutoukas P; Tsaganos T; Tziortzioti V; Panagou C; Adamis T; Giamarellou H
BMC Infect Dis; 2006 Feb; 6():31. PubMed ID: 16504031
[TBL] [Abstract][Full Text] [Related]
8. Impact of cefuroxime administration on endotoxin (LPS) and tumour necrosis factor-alpha (TNFalpha) blood levels in patients suffering from acute pyelonephritis: a preliminary report.
Giamarellou-Bourboulis EJ; Perdios J; Lelekis M; Eoconomou E; Tsouroulas P; Giamarellou H
Int J Antimicrob Agents; 1999 Feb; 11(2):115-9. PubMed ID: 10221414
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-2 associations with the underlying infection and sepsis severity.
Lymperopoulou K; Velissaris D; Kotsaki A; Antypa E; Georgiadou S; Tsaganos T; Koulenti D; Paggalou E; Damoraki G; Karagiannidis N; Orfanos SE
Cytokine; 2015 May; 73(1):163-8. PubMed ID: 25748839
[TBL] [Abstract][Full Text] [Related]
10. Early increase of serum angiopoietin-2 are associated with early progression to death in experimental injury.
Koutsostathis S; Tsaganos T; Lallos S; Georgitsi M; Roumeliotis L; Giamarellos-Bourboulis EJ; Efstathopoulos N
Cytokine; 2011 Dec; 56(3):817-22. PubMed ID: 22024411
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the release of Ang-2 in experimental endotoxic shock by a species-specific circulating factor.
Carrer DP; Kotzampassi K; Fyntanidou B; Grosomanidis V; Papapetropoulos A; Lymperi M; Giamarellos-Bourboulis EJ
Injury; 2013 Jul; 44(7):935-40. PubMed ID: 23642845
[TBL] [Abstract][Full Text] [Related]
12. Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis.
Kümpers P; van Meurs M; David S; Molema G; Bijzet J; Lukasz A; Biertz F; Haller H; Zijlstra JG
Crit Care; 2009; 13(3):R64. PubMed ID: 19416526
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory intervention with interferon-γ in Escherichia coli pyelonephritis.
Katsaris MP; Adamis T; Pistiki A; Carrer DP; Galani I; Sabracos L; Droggiti DI; Georgitsi M; Damoraki G; Giamarellos-Bourboulis EJ; Chrisofos M
J Urol; 2014 Aug; 192(2):600-6. PubMed ID: 24681329
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial-induced endotoxaemia in patients with sepsis in the field of acute pyelonephritis.
Giamarellos-Bourboulis EJ; Perdios J; Gargalianos P; Kosmidis J; Giamarellou H
J Postgrad Med; 2003; 49(2):118-22. PubMed ID: 12867685
[TBL] [Abstract][Full Text] [Related]
16. The level of endotoxemia in sepsis varies in relation to the underlying infection: Impact on final outcome.
Kritselis I; Tzanetakou V; Adamis G; Anthopoulos G; Antoniadou E; Bristianou M; Kotanidou A; Lignos M; Polyzos K; Retsas T; Sassopoulou P; Papaioannou AI; Sinapidis D; Sereti K; Vittoros V; Ghanas P; Gogos C; Giamarellos-Bourboulis EJ
Immunol Lett; 2013 May; 152(2):167-72. PubMed ID: 23747516
[TBL] [Abstract][Full Text] [Related]
17. Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.
Giamarellos-Bourboulis E; Adamis T; Sabracos L; Raftogiannis M; Baziaka F; Tsaganos T; Koutoukas P; Plachouras D; Karayannacos P; Giamarellou H
Scand J Infect Dis; 2005; 37(1):48-54. PubMed ID: 15764190
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2 primes infection-induced preterm delivery.
Polyzou EN; Evangelinakis NE; Pistiki A; Kotsaki A; Siristatidis CS; Chrelias CG; Salamalekis E; Kassanos DP; Giamarellos-Bourboulis EJ
PLoS One; 2014; 9(1):e86523. PubMed ID: 24466134
[TBL] [Abstract][Full Text] [Related]
19. The impact of multidrug resistance on the pathogenicity of Escherichia coli: an experimental study.
Bristianou M; Panagou C; Adamis T; Raftogiannis M; Antonopoulou A; Chrisofos M; Galani I; Kanellakopoulou K; Tsaganos T; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2008 Mar; 31(3):216-23. PubMed ID: 18248963
[TBL] [Abstract][Full Text] [Related]
20. Esmolol: immunomodulator in pyelonephritis by Pseudomonas aeruginosa.
Dimopoulos G; Theodorakopoulou M; Armaganidis A; Tzepi IM; Lignos M; Giamarellos-Bourboulis EJ; Tsaganos T
J Surg Res; 2015 Sep; 198(1):175-84. PubMed ID: 26073350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
